I reviewed every one and It appeared that you hadn't read them; many have no bearing on the discussion, and at least one provides direct evidence in favor of physiological dosing. None support the premise that supraphysiological dosing is preferable to physiological dosing for treating hypogonadism.
For those who are interested, the discussion begins around here:
Male. Mid 50’s.
Symptoms prior to TRT: excessive fatigue, no energy, brain fog, difficulty concentrating, depression, anxiety, low libido, loss of muscle mass, reduced strength.
Prior to TRT, my total testosterone was 460. I know that may sound high to start TRT but I have been searching for a solution to my symptoms for a long time. My doctors have ruled out Vitamin D, B12, Folate, Anemia, infections, liver, kidney, hydration, thyroid, Iron, etc. Even at 460, I needed to see if TRT could help. I started with a low dose, waited 3 months, did my labs, and here I am.
I started TRT 3...
AI Summary:
The key debate in the
ExcelMale thread (primarily on page 3) between Cataceous and Phil Goodman centers on optimal TRT dosing strategy: physiological replacement (aiming to mimic or restore natural, mid-to-high normal testosterone levels) versus somewhat supraphysiological (higher-than-natural levels for perceived greater benefits in well-being, energy, etc.).
Cataceous's Main Positions (Advocating Physiological Doses)
- Physiological dosing is safer and more logical: Start with modest doses to replicate healthy natural production (equivalent to ~50-70 mg testosterone cypionate/week for young men; top natural range ~90 mg/week). 100 mg/week is already supraphysiological for most, often leading to peaks well above normal (e.g., user's trough free T of 31.91 ng/dL — above the 5-21 range — implies even higher peaks).
- No strong evidence for supraphysiological benefits beyond muscle: Higher doses don't reliably improve non-muscular outcomes (energy, mood, cognition) and may cause imbalances across dozens of hormones. Testosterone isn't directly tied to energy/focus at supraphysiological levels; excess can worsen symptoms (e.g., sleep issues, libido problems, raised HCT, poor lipids).
- Risks of starting too high: Immediate exposure to supraphysiological levels (especially with infrequent injections) skips the chance to experience true physiological restoration first. Suggests experimenting with lower doses (e.g., 40 mg twice weekly) or faster-acting forms to minimize prolonged high exposure and long-term risks.
- Counters community anecdotes: Dismisses polls showing many feel better at higher levels, arguing they're biased toward those already on supraphysiological doses rather than true physiological ones.
Phil Goodman's Main Positions (Advocating Somewhat Supraphysiological Doses)
- Higher levels often feel better anecdotally: Cites community polls (e.g., 68% of members report feeling better with above-normal levels), suggesting many men need/respond better to doses pushing levels somewhat supraphysiological for optimal symptom relief (libido, muscle, strength, energy).
- Dismisses excessive concern over ratios/free T/SHBG: Low SHBG (common on TRT) makes users less tolerant to estrogen but doesn't inherently require ultra-low doses; % free T or ratios aren't the main issue. Nothing much can be done about low SHBG anyway, and it shouldn't dominate symptom troubleshooting.
- Adjustment takes time: Users may see partial improvements (e.g., better libido/muscle) but need more time or slight tweaks rather than immediately dropping to very low doses.
Key Back-and-Forth Exchanges/Rebuttals
- Cataceous challenges the "100 mg/week is low/normal" myth as pervasive but incorrect, urging lower starting doses to avoid supraphysiological exposure from the outset.
- Phil pushes back with poll data and community experience, arguing higher doses work well for most without needing to obsess over SHBG or free T ratios.
- Cataceous rebuts that many "higher-level" successes likely stem from supraphysiological exposure (not true physiological restoration), and risks (e.g., vascular issues, cardiac strain from studies) increase dose-dependently beyond physiological.
- The debate ties into the original poster's labs (high free T at trough, low-ish SHBG), with Cataceous recommending dose reduction (e.g., to ~40 mg twice weekly) to stabilize levels and potentially raise SHBG, while Phil leans toward patience and accepting higher ranges if symptoms improve partially.
Overall, Cataceous emphasizes evidence-based caution, risk minimization, and physiological mimicry as the default, while Phil leans on real-world forum anecdotes and optimization for subjective well-being even if it means exceeding natural levels. The discussion remains civil but pointed, highlighting a broader divide in the TRT community. For full context, refer to page 3 of the thread:
New to TRT. Received first labs. Concerned and need help. - Page 3 - ExcelMale - #1 TRT & Testosterone Forum | Expert-Moderated Men's Health Community
1.) that isn’t the thread with the full discussion
2.) Funny how it says I leaned on real-world form anecdotes when I shared numerous studies which all found 100-120 mg/week to be closer to the sweet spot of the U-curve than the other doses.
3.) the original discussion was here:
First off, an advance thank you for the wealth of information I have learned here. I have learned so much browsing as a guest and wish I knew half of what most of you have forgotten.
I am prescribed 200mg/week of Testosterone from my
Urologist. I have been on since early 2022.
When tested prior to TRT- I had three tests that all had to be drawn by 8:00AM and my highest was 108ng/dl. Lowest and average was 96ng/dl.
No past drug, anabolics abuse. I drank a lot in my 30’s. Was a little overweight. No injury. The only medical condition is asthma that at times has required a lot of...
AI recap:
OVERVIEW OF THE DISCUSSION BETWEEN CATACEOUS AND PHIL GOODMAN
The debate between Cataceous and Phil Goodman centers on one primary question:
What testosterone dose should men start with when beginning TRT?
Their disagreement reflects two broader philosophies in TRT treatment.
Cataceous argues that TRT should mimic natural physiological testosterone production as closely as possible. Phil Goodman argues that starting doses around 100–120 mg per week are reasonable and often more effective for symptom relief.
In other words, the debate is less about TRT itself and more about how aggressively it should be used.
CORE POSITIONS
Cataceous' Position
Cataceous takes a physiology-first approach. His argument is that TRT should attempt to replicate the body's natural testosterone production rather than exceed it.
His main points include:
- Natural testosterone production in healthy males is roughly 3–9 mg per day.
- When converted to injectable equivalents, this corresponds roughly to about 30–90 mg per week.
- Starting TRT doses should therefore fall roughly in the 40–80 mg per week range.
- Doses around 100 mg or higher may be supraphysiological for many men.
- Higher doses can increase risks such as lipid deterioration, elevated hematocrit, cardiovascular strain, and estrogen-related side effects.
His broader philosophy is that TRT should prioritize long-term systemic health rather than performance or body composition improvements.
Phil Goodman's Position
Phil Goodman argues from a more symptom-driven and outcome-focused perspective.
His main points include:
- Clinical studies frequently use doses around 100–125 mg per week.
- These doses often produce strong improvements in symptoms such as fatigue, libido, mood, and body composition.
- Starting doses that are too low may fail to relieve symptoms, leading to unnecessary suffering for patients.
- Injectable testosterone pharmacokinetics differ from natural production, so direct mg-to-mg comparisons may be misleading.
- Patient outcomes and quality of life should be prioritized over strict adherence to theoretical physiological production numbers.
His philosophy places more weight on real-world treatment outcomes and symptom relief.
MAIN POINTS OF DISAGREEMENT
- What counts as “physiological”
Cataceous argues that TRT should approximate natural production levels.
Phil argues that injectable testosterone behaves differently and that natural production numbers do not translate directly to injection dosing.
- Interpretation of clinical studies
Phil references studies using ~100–125 mg per week showing significant benefits with manageable risks.
Cataceous argues those studies do not properly demonstrate what the true minimum effective physiological replacement dose should be.
- Risk tolerance
Cataceous emphasizes minimizing long-term health risks by keeping testosterone levels closer to natural ranges.
Phil argues that the risks of moderate dosing are often overstated and that many men tolerate 100–120 mg well.
- Treatment philosophy
Cataceous views TRT primarily as hormone replacement.
Phil views TRT as hormone optimization aimed at improving quality of life.
POINTS THEY ACTUALLY AGREE ON
Despite the disagreement, both participants share several views:
- Extremely high TRT doses (150–200+ mg/week) are often unnecessary.
- Individual response varies significantly between patients.
- Protocol stability and symptom management are important.
- Excessive medication stacking (AI, multiple compounds, etc.) can complicate treatment.
INSIGHT FROM THE DISCUSSION
This debate highlights a broader divide within the TRT community.
There are two major schools of thought:
Medical Restoration Approach
TRT should restore natural physiological hormone levels and prioritize long-term health markers.
Optimization Approach
TRT should prioritize symptom relief, quality of life, and functional improvements, even if testosterone levels are somewhat above natural production ranges.
to improve well-being versus how str
